House lawmakers from both parties pressed health insurance executives on a blunt question Thursday. Why executive pay keeps climbing while patients struggle to cover care.
The issue surfaced during a hearing before the Energy and Commerce Health Subcommittee focused on affordability. Five insurance CEOs testified. The tone sharpened fast.
Rep. Buddy Carter, a Republican from Georgia, zeroed in on compensation at CVS Health. He asked CEO David Joyner why the company spent $41 mn paying Joyner and another executive in 2024.
Carter said the amount could cover premiums for thousands of families. He asked how such pay squares with patients squeezed by rising premiums.
Joyner pushed back. He said the figure cited did not reflect his personal compensation. Joyner said he earned $17 mn last year, with $1.1 mn as base salary.
The remainder came through long-term incentives tied to performance. He also said he returned his bonus to a relief fund for CVS Health employees.
Carter didn’t let it slide. He said pharmacists he recently met helped generate the revenue behind Joyner’s pay. The remark landed pointed and personal.
Democrats joined the critique. Rep. Nanette Diaz Barragan of California said executive pay structures rely heavily on stock awards and performance bonuses.
She said those incentives steer attention toward share price and margins rather than patients.
Barragan said her constituents ask why insurance executives earn so much while families stretch every dollar for coverage, only to see claims denied. The contrast, she said, keeps widening.
